Synthetic LXR Agonist Suppresses Endogenous Cholesterol Biosynthesis and Efficiently Lowers Plasma Cholesterol

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|2|285-292

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.2, 2011-02, pp. : 285-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ezetimibe lowers LDL-cholesterol levels

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Ezetimibe/simvastatin lowers LDL-cholesterol to target levels

By  

Inpharma, Vol. 1, Iss. 1628, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Effect of the synthetic resorcinol derivative of caryophyllene on cholesterol biosynthesis and the functional activity of immune system cells

By Kudinova E.   Salakhutdinov N.   Fomenko V.   Vol’skii N.   Perminova O.   Khoshchenko O.   Shwarts Y.   Dushkin M.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 10, 2006-10 ,pp. : 540-543

Springer Publishing Company

Access to resources Recommend Favorite

Cholesterol and plasma lipid modifying patents

By Suckling K.E.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 11, 1998-11 ,pp. : 1415-1423

Informa Healthcare

Access to resources Recommend Favorite

The ACAT Inhibitor HL-004 Inhibits Cholesterol Absorption and Lowers Serum Cholesterol in Rats - stimulation of bile acid production by HL-004

By Asami Y.   Kondo Y.   Murakami S.   Araki H.   Tsuchida K.   Higuchi S.  

General Pharmacology, Vol. 31, Iss. 4, 1998-10 ,pp. : 593-596

Elsevier

Access to resources Recommend Favorite